Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Double Blind Randomized Controlled Trial of High Dose Vitamin B12 in Septic Shock

NCT03783091 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT03783091
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03783091 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Double Blind Randomized Controlled Trial of High Dose Vitamin B12 in Septic Shock
Lead sponsor
Medical College of Wisconsin
Phase
Phase 2
Overall status
Completed
Start date
August 5, 2019
Completion date
February 23, 2023
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock